Skip to main content

Array BioPharma Aktie - Fundamentalanalyse - Dividendenrendite KGV

Array BioPharma (ISIN: US04269X1054, WKN: 580564) Kursdatum: 17.11.2017 Kurs: 11,520 USD
Beschreibung Daten
Symbol ARRY
Marktkapitalisierung 1.880.144.640,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Pharma
Rohdaten nach US GAAP in Millionen USD
Aktiensplits
Internet www.arraybiopharma.com
Letztes Bilanz Update 29.09.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 17.11.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
-43,85 -47,78 0,00% -42,10 4,20 -16,00 12,46 160,33

Firmenbeschreibung

SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)The tables below summarize our unaudited quarterly operating results for the fiscal years ended June 30, 2016 and 2015 (dollars in thousands, except per share data):Fiscal Year Ended June 30, 2016 First Quarter Second Quarter Third Quarter Fourth QuarterRevenue $16,197 $35,430 $43,047 $43,205Research and development for proprietary programs $20,998 $41,351 $48,802 $49,504Total operating expenses $34,568 $56,952 $63,055 $65,513Net loss $(20,987) $(24,164) $(22,675) $(25,014)Net earnings (loss) per share – basic $(0.15) $(0.17) $(0.16) $(0.17)Net earnings (loss) per share – diluted $(0.15) $(0.17) $(0.16) $(0.17)Weighted average shares outstanding – basic 142,216 142,833 143,338 143,475Weighted average shares outstanding – diluted 142,216 142,833 143,338 143,475Fiscal Year Ended June 30, 2015 First Quarter Second Quarter Third Quarter Fourth QuarterRevenue $6,069 $26,919 $6,601 $12,320Research and development for proprietary programs $12,190 $11,817 $11,817 $18,618Total operating expenses $31,166 $32,993 $32,144 $33,964Net income (loss) $(27,593) $(8,611) $58,307 $(12,734)Net earnings (loss) per share – basic $(0.21) $(0.06) $0.42 $(0.09)Net earnings (loss) per share – diluted $(0.21) $(0.06) $0.37 $(0.09)Weighted average shares outstanding – basic 131,826 133,815 139,769 141,393Weighted average shares outstanding – diluted 131,826

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.arraybiopharma.com